New Parkinson’s Disease Model Accelerates Drug Development
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development. Parkinson’s disease is defined in part by the formation of protein aggregates inside neurons known as Lewy bodies. These intracellular inclusions are … Read more